This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (15)  • Contact me when this article is cited  Related Content  • Related letters  • Similar articles in this journal  Topic Collections  • Oncology  • Laryngology/ Speech/ Language Pathology  • Neoplasms of Head & Neck  • Radiation Therapy  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

Amy Y. Chen, MD, MPH; Michael Halpern, MD, PhD

Arch Otolaryngol Head Neck Surg. 2007;133(12):1270-1276.

Objective  To determine the factors predictive of improved survival among patients with advanced laryngeal cancer.

Design  National hospital-based cancer registry.

Patients  Patients treated with total laryngectomy (TL), radiation therapy alone (RT), or combined chemotherapy and radiation therapy (chemo-RT).

Results  Of the 10 590 patients meeting the initial inclusion criteria, 7019 had appropriate nonmissing values in all study variables and were included in the analysis. Overall, TL was significantly associated with increased likelihood of survival compared with RT or chemo-RT (P<.001). Among patients with stage III cancer, TL and chemo-RT had similar impacts on survival (each showed increased survival compared with RT), whereas TL was associated with significantly greater survival than chemo-RT or RT among patients with stage IV disease (P<.001). Overall survival was also decreased among men, black patients (compared with white patients), and patients with Medicare or Medicaid or those who were uninsured (compared with those with private insurance).

Conclusions  Among patients with the most advanced disease (stage IV), TL was associated with increased survival compared with chemo-RT or RT, whereas both TL and chemo-RT improved survival over RT among patients with stage III cancer. Insurance type and black race also showed significant associations with survival, which may reflect barriers in access to care (P<.001).

Author Affiliations: Department of Otolaryngology, Emory University (Dr Chen), and Department of Health Services Research, American Cancer Society (Drs Chen and Halpern), Atlanta, Georgia.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Lymph Node Status Cannot Be Ignored in Survival Analysis of Laryngeal Cancer
Shilpa S. Chatni and Krishnakumar Thankappan
Arch Otolaryngol Head Neck Surg. 2008;134(7):786.
EXTRACT | FULL TEXT  

Lymph Node Status Cannot Be Ignored in Survival Analysis of Laryngeal Cancer—Reply
Amy Y. Chen and Michael T. Halpern
Arch Otolaryngol Head Neck Surg. 2008;134(7):786-787.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Insurance Status, Comorbidity Level, and Survival Among Colorectal Cancer Patients Age 18 to 64 Years in the National Cancer Data Base From 2003 to 2005
Robbins et al.
JCO 2009;27:3627-3633.
ABSTRACT | FULL TEXT  

Tradition, Teamwork, and Tailored Treatment: Surgical Oncology in the Genomic Era
Wolf
Arch Otolaryngol Head Neck Surg 2009;135:337-341.
FULL TEXT  

Lymph Node Status Cannot Be Ignored in Survival Analysis of Laryngeal Cancer
Chatni and Thankappan
Arch Otolaryngol Head Neck Surg 2008;134:786-786.
FULL TEXT  

Lymph Node Status Cannot Be Ignored in Survival Analysis of Laryngeal Cancer--Reply
Chen and Halpern
Arch Otolaryngol Head Neck Surg 2008;134:786-787.
FULL TEXT